Back
Ultragenyx Pharmaceutical Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
41
RARE
Ultragenyx Pharmaceutical
Last Price:
$37.53
Seasonality Move:
11.08%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.48 | Buy |
| 20-day SMA: | 35.85 | Buy |
| 50-day SMA: | 35.75 | Buy |
| 200-day SMA: | 44.94 | Sell |
| 8-day EMA: | 36.68 | Buy |
| 20-day EMA: | 36.23 | Buy |
| 50-day EMA: | 36.74 | Buy |
| 200-day EMA: | 41.53 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 57.13 | Buy |
| Chaikin Money Flow: | -242112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.67 - 36.73) | Buy |
| Bollinger Bands (100): | (35.13 - 42.25) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 37.51 while RARE 8-day simple moving average is 36.48, which is a Buy signal.
-
The stock price of RARE is 37.51 while Ultragenyx Pharmaceutical 20-day SMA is 35.85, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 35.75 while RARE share price is 37.51, making it a Buy technically.
-
RARE stock price is 37.51 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.94, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
41
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $37.51. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.5B
Price in USD:
37.51
Share Volume:
1.2M
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
29.59
Sell
41
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 37.51 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 37.51 while RARE 8-day exponential moving average is 36.68, which is a Buy signal.
-
The stock price of RARE is 37.51 while Ultragenyx Pharmaceutical 20-day EMA is 36.23, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 36.74 while RARE share price is 37.51, making it a Buy technically.
-
RARE stock price is 37.51 and Ultragenyx Pharmaceutical 200-day simple moving average is 41.53, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.37 per share, an increase this year of $0.84 per share, and an increase next year of $1.76 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Ultragenyx Pharmaceutical is a Buy
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 57.13, which suggest Ultragenyx Pharmaceutical is overbought
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (34.67 - 36.73), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (35.13 - 42.25), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.